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Abstract 
Background: Access to primary care is important for the identification, control and management of 
cardiometabolic risk factors (CMRFs). This study investigated whether differences in geographic access 
to primary care explained area-level variation in CMRFs. Methods: Multilevel logistic regression models 
were used to derive the association between area-level access to primary care and seven discrete CMRFs 
after adjusting for individual and area-level co-variates. Two-step floating catchment area method was 
used to calculate the geographic access to primary care for the small areas within the study region. 
Results: Geographic access to primary care was inversely associated with low high density lipoprotein 
(OR 0.94, CI 0.91–0.96) and obesity (OR 0.91, CI 0.88–0.93), after adjusting for age, sex and area-level 
disadvantage. The intra-cluster correlation coefficient (ICCs) of all the fully adjusted models ranged 
between 0.4–1.8%, indicating low general contextual effects of the areas on CMRF distribution. The area-
level variation in CMRFs explained by primary care access was ≤10.5%. Conclusion: The findings of the 
study support proportionate universal interventions for the prevention and control of CMRFs, rather than 
any area specific interventions based on their primary care access, as the contextual influence of areas 
on all the analysed CMRFs were found to be minimal. The findings also call for future research that 
includes other aspects of primary care access, such as road-network access, financial affordability and 
individual-level acceptance of the services in order to gain an overall picture of the area-level contributing 
role of primary care on CMRFs in the study region. 
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Abstract: Background: Access to primary care is important for the identification, control and management 
of cardiometabolic risk factors (CMRFs). This study investigated whether differences in geographic 
access to primary care explained area-level variation in CMRFs. Methods: Multilevel logistic regression 
models were used to derive the association between area-level access to primary care and seven discrete 
CMRFs after adjusting for individual and area-level co-variates. Two-step floating catchment area 
method was used to calculate the geographic access to primary care for the small areas within the study 
region. Results: Geographic access to primary care was inversely associated with low high density 
lipoprotein (OR 0.94, CI 0.91–0.96) and obesity (OR 0.91, CI 0.88–0.93), after adjusting for age, sex and 
area-level disadvantage. The intra-cluster correlation coefficient (ICCs) of all the fully adjusted models 
ranged between 0.4–1.8%, indicating low general contextual effects of the areas on CMRF distribution. 
The area-level variation in CMRFs explained by primary care access was ≤10.5%. Conclusion: The 
findings of the study support proportionate universal interventions for the prevention and control of 
CMRFs, rather than any area specific interventions based on their primary care access, as the contextual 
influence of areas on all the analysed CMRFs were found to be minimal. The findings also call for future 
research that includes other aspects of primary care access, such as road-network access, financial 
affordability and individual-level acceptance of the services in order to gain an overall picture of the 
area-level contributing role of primary care on CMRFs in the study region. 
Keywords: geographic access; cardiometabolic risk factor; geographic variation; multilevel logistic 
regression; primary care access 
 
1. Introduction 
Cardiometabolic risk factors (CMRFs) demonstrate significant variation in geographic distribution 
within countries globally [1–10]. Higher prevalence and clustering of CMRFs is often reported for 
socioeconomically disadvantaged areas [11–20]. Reachability or geographic access to primary care is 
essential for the individual-level identification and management of CMRFs, especially when considering 
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their chronic nature after detection [21–23]. Therefore, access to primary care may be associated with the 
geographic variation of CMRFs [24]. 
Previous studies have reported that access to primary care can play a role in the control and 
management of certain CMRFs [21,25–28]. The dimensions of access to primary care can be fundamentally 
conceptualized into 1) physical access 2) affordability and 3) acceptability [29]. Research indicates that the 
physical access to primary care varies across areas, as the locations of primary care physicians and services 
tend to be positively correlated with population density [30,31]. There is also evidence that medical 
consultations were reported less likely to happen when physical access to health care services is lower 
[21]. In addition, access to adequate treatment facilities were reported to have an inverse association with 
certain CMRFs, such as hypertension [25,26], end stage renal disease [27] and diabetes mellitus [32]. 
However, these reports are based on individual CMRFs but consistent evidence across a range of CMRFs 
may provide a stronger evidence base for healthcare service commissioning across areas. 
Evidence regarding the association of CMRFs with primary care access over and above area-level 
disadvantage may also inform area-level resource allocation of primary care services in disadvantaged 
areas [24,33]. Therefore, the aims of this study were to: 1) identify the area-level association of individual 
CMRFs with geographic access to primary care; 2) quantify the general contextual effect of areas on 
CMRFs; and 3) quantify the geographic variation in CMRFs explained by differences in area-level primary 
care access, within the Illawarra-Shoalhaven region of Australia. 
2. Materials and Methods 
A retrospective cross-sectional design and multilevel logistic regression models were adopted to 
meet the study objectives. The study was approved by the University of Wollongong and Illawarra and 
Shoalhaven Local Health District Health and Medical Human Research Ethics Committee (HREC protocol 
No: 2017/124). 
The study focused on the Illawarra-Shoalhaven region of New South Wales (NSW), Australia. This 
area consists of multiple regional cities, smaller towns and rural areas, including the local government 
areas of Kiama, Shellharbour, Shoalhaven and Wollongong. The region covers a geographical area of 5615 
square kilometres and had a population of 369,469 people at the 2011 Australian Census of Population 
and Housing [34,35]. The geographic unit of analysis used in this study was the Statistical Area 1 (SA1), 
which is the smallest statistical output unit of the 2011 Census and which has an average population of 
400 people (range: 200 to 800) [36]. The study area encompassed 980 conterminous SA1s [37]. Figure 1 
shows the study area showing SA1s and major landmarks of the region. 
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Figure 1. Map of the Illawarra-Shoalhaven region of NSW, Australia, showing SA1 areas and major 
landmarks. 
2.1. Data 
The study used three different databases: (1) the CMRF pathology test data; (2) primary care provider 
data; and (3) the estimated resident populations from the 2011 Australian Census of Population and 
Housing. The CMRF test data were extracted from the Southern IML Research (SIMLR) Study database. 
The SIMLR Study database comprises de-identified and internally linked pathology results from a major 
pathology provider in the study region and provides near-census coverage of the study population [8]. 
The CMRF test data were extracted for multiple risk factors on the most recent test results, of non-
pregnant adults aged 18 years and over, undergoing a laboratory test between 1 January 2012 and 31 
December 2017. 
The primary care provider data were manually extracted in 2016 from publicly available data 
sources, including Yellow Pages, White Pages, online general practitioner (GP) appointment booking 
services and Google search results. The 2011 Australian Census of Population and Housing data were 
accessed to extract the population denominator data of the study region at SA1 level [34]. 
2.2. Dependent Variable 
Dichotomised results of the individual CMRF tests were the dependent variables in this study. The 
CMRF test results included: fasting blood sugar level (FBSL); glycated haemoglobin (HbA1c); total 
cholesterol (TC); high density lipoprotein (HDL); urinary albumin creatinine ratio (ACR); estimated 
glomerular filtration rate (eGFR); and objectively measured body mass index (BMI). The pathology 
service routinely collects BMI for each of the remaining CMRF tests and thus became available for 
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analyses in this study [12]. However, it should be noted that the data do not include blood pressure 
readings. Although blood pressure is an important CMRF it is not routinely collected with any of the 
pathology test samples and thus not available for analyses in this study. During analyses, all the retrieved 
CMRF test results were dichotomised into higher risk and lower risk values based on established risk 
classification guideline values. Table 1 shows the CMRF definitions adopted in this study to dichotomies 
the test results. 
Table 1. Definitions of CMRF (cardiometabolic risk factor) test results. 
 Higher risk CMRFs Definition 
1. High FBSL FBSL ≥ 7.0 mmol/L [38]. 
2. High HbA1c HbA1c > 7.5% [38]. 
3. High TC TC ≥ 5.5 mmol/L [39]. 
4. Low HDL HDL < 1 mmol/L [40]. 
5. High ACR ACR ≥ 30 mcg/L to mg/L [41]. 
6. Low eGFR eGFR < 60 mL/min/1.73 m2 [41]. 
7. Obesity BMI ≥ 30 kg/m2 [42]. 
CMRFs—cardiometabolic risk factors; FBSL—fasting blood sugar level; HbA1c—glycated 
haemoglobin; TC—total cholesterol; HDL—high density lipoprotein; ACR—albumin creatinine 
ratio; eGFR—estimated glomerular filtration rate; BMI—body mass index. 
2.3. Independent Variable 
Primary care access index calculated for the small areas at SA1-level was the independent study 
variable. An access index score was calculated for each SA1 using a two-step floating catchment area 
(2SFCA) method, which balanced both supply and demand of primary care services in the study region. 
The 2SFCA method was developed by Luo and Wang in 2003 to measure geographic accessibility of 
health care services [43]. The method has undergone several enhancements since its inception but 
essentially consists of two steps underpinned by a gravity model [43,44]. The first step computes a 
population-to-provider ratio for each primary care service location by aggregating the population size of 
the SA1s whose centroids (i.e., the geometric centers) are located within a defined spatial buffer distance 
[45]. The total number of general practitioners working in the primary care service locations within this 
buffer distance were the numerators for the provider-to-population ratio calculations. 
Thus, step 1: 
   =
  
∑    
                       (1) 
where Sj is the number of general practitioners at location j, pi is the number of adult residents in the 
SA1s (those SA1 geographic centroids are located within the spatial buffer distance of the primary care 
locations) and Rj is the population-to-provider ratio for service j [45]. 
In step 2, a population-to-provider ratio (access score) is computed for each geographic centroid of 
the SA1s by aggregating all primary care service population-to provider ratios of the primary care services 
that are located within the same spatial buffer distance [45]. 
Thus, step 2: 
   = ∑                            (2) 
where Ai is the access index for population location i. 
The resulting access indices were retained as a continuous variable for the analyses. A higher score 
indicated better geographic access of the SA1s to primary care services. 
A spatial radial buffer distance of 30 km was chosen to compute primary care access for SA1s in the 
study region. In the preliminary stage, sensitivity analyses were performed using 1 km, 16 km and 30 km 
spatial radial buffer distances. In step 1 2SFCA analyses, the 1 km distance covered only 545 (56%) SA1 
centroids in the study region in relation to the primary care provider locations, whereas a 16 km radial 
buffer distance covered 973 (~99%) and a 30 km radial buffer distance covered 978 (~100%) SA1s’ 
geographic centroids. Therefore, a radial buffer distance of 30 km was chosen to determine the access 
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which was observed to cover the mixed rural, semi-rural and urban distribution of the population in the 
study region well. 
2.4. Covariates 
The individual-level variables adjusted at SA1-level were: sex (male and female) and age group (18–
29, 30–39, 40–49, 50–59, 60–69, 70–79 and 80+ years). The area-level covariate adjusted at SA1-level was 
the area-level socioeconomic disadvantage. The Index of Relative Socioeconomic Disadvantage (IRSD) 
score of the SA1s in the study region based on the 2011 Australian Bureau of Statistics conducted census 
of population and housing was used as the measurement variable for the area-level socioeconomic 
disadvantage of the SA1s [37]. The IRSD summarises a range of measures of relative socioeconomic 
disadvantage of people and/or households within SA1s and includes: level of income; education; 
employment; family structure; disability; housing; transportation; and internet connection [37]. A higher 
IRSD score indicated lower levels of disadvantage [37]. The Illawarra-Shoalhaven region has a diverse 
socio-economic profile, making this landscape useful for area-level population health studies [46]. 
2.5. Statistical Analyses 
Multilevel logistic regression models were fitted to individual CMRF test data at the SA1 level. For 
each of the seven CMRFs analysed in this study, five nested models were fit that included fixed effects for 
access index after adjusting for sex, age and IRSD score; and random effect intercepts for SA1s. In the 
nested models, Model 1 (M1) was a null model of CMRF at SA1-level; Model 2 (M2) included the area-
level study variable (access index) only; Model 3 (M3) included individual-level factors at SA1-level (age 
and sex) only; Model 4 (M4) included individual and area-level factors (age, sex and IRSD score) at SA1-
level; and Model 5 (M5) included M4 variables plus access index. Thus, the final model (M5) estimated 
the effect of primary care access after adjusting for individual and area-level factors. Odds ratios (ORs) 
were derived from the exponentials of regression coefficients from fitted models. As the IRSD scores and 
access index of the SA1s were fitted as mean-centred continuous variables, ORs were expressed per 
standard deviation unit change in these variables. Statistical significance of the models was evaluated 
using likelihood ratio tests and a type I error rate of 0.05. 
2.6. Model Comparison 
Model fit was compared using the Akaike Information Criterion (AIC). The models were also 
evaluated for: area-level variance (τ2); proportional change in variance (PCV) in comparison with the null 
model; intra-cluster correlation coefficient (ICC) of the model; and the median odds ratios (MORs). The 
ICC and MOR of the models were used to index the between-area variability. A latent variable approach 
was used to derive the ICC of models [47]. The MOR translates the area-level variance into an easily 
interpretable OR and is assumed to be statistically independent of the test specific prevalence of the 
CMRFs [48]. The unique contribution of the primary care access of the SA1s to the area-level variance of 
CMRF was estimated through the reduction in PCV between M4 and M5. 
2.7. Statistical Package 
All mapping and geospatial measurements were performed using ArcGIS version 10.4.1 (ESRI Inc. 
Redlands, CA, USA) [49]. All statistical analyses were performed using R version 3.4.4. (R Foundation for 
Statistical Computing, Vienna, Austria) [50]. Multilevel models were fit using the glmer function in the 
lme4 package [51]; and likelihood ratio tests were calculated using the lrtest function in the lmtest package 
[52]. The glmer function fit the generalized linear mixed model, which incorporates both fixed-effects 
parameters and random effects in a linear predictor, via maximum likelihood [53,54]. 
3. Results 
A total of 1,132,029 CMRF test results for 256,525 individual residents in the Illawarra-Shoalhaven 
region between 2012 and 2017 were extracted for analysis. The mean number of tests undertaken per 
person was 4.4 (SD = 1.8, range = 1–7). After excluding 1162 (1.0%) test results with incomplete details, a 
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total of 1,130,894 tests were retained in the final data set. IRSD scores of the SA1s were the most frequent 
missing variable, as this was not available for some SA1s in the study region [55]. Available IRSD scores 
ranged between 446.7 and 1143.7 (mean = 976.7, SD = 98.6) for SA1s, with a higher score indicating lower 
area-level disadvantage. Table 2 details the individual-level CMRFs risk proportions of the final data set. 
Table 2. Frequency and proportion of CMRFs risk classification with gender. 
 Cardiometabolic Risk  
Test  
n  
Higher Risk 
n (%) * 
Male  
n (%) * 
Female 
n (%) * 
1. High FBSL 193,679  16,280 (8.4) 9289 (4.8) 6991 (3 .6) 
2. High HbA1c 73,885 7927 (10.7) 4448 (6.0) 3479 (4.7) 
3. High TC 194,816 63,422 (32.6) 26,139 (13.4) 37,283 (19.1) 
4. Low HDL 182,237  21,261 (11.7) 15,885 (8.7) 5376 (3.0) 
5. High ACR 50,790 2047 (4.0) 1266 (2.5) 781 (1.5) 
6. Low eGFR 244,166 27,241 (11.2) 12,456 (5.1) 14,785 (6.1) 
7. Obesity 192,455 64,832 (33.7) 29,613 (15.4) 35,319 (18.4) 
* The denominators of the percentages are the total number of each CMRF tests. 
For primary care access, a total of 165 primary care service locations with 611 general practitioners 
were identified in the study area in 2016. The primary care access index of the SA1s in the study region 
ranged between 0 and 5.41 general practitioners per 1000 people (mean = 2.1, SD = 0.77). Figure 2 illustrates 
the distribution of the primary care access index within the study region. 
 
Figure 2. Geographic access to primary care services in the Illawarra-Shoalhaven region of the NSW, 
Australia. 
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Multilevel logistic regression models for each CMRF are presented in Tables 3–9. The null models 
indicated significant geographic variation in the distribution of all CMRFs at the SA1 level. Model 2s 
showed inverse associations between access index and all CMRFs except TC, which displayed a positive 
association with the access index. Model 3s adjusted CMRF models for individual-level age and sex, 
which accounted for 1.5% (obesity) to 87.3% (eGFR) of unexplained variation in the null model. The 
general contextual effect of areas over and above their individual composition, such as age and sex, is 
obtained by a measure of clustering (i.e., ICCs) in the model 3s, which ranged between 0.6–3.4% in the 
CMRFs models presented. Model 4s demonstrated significant inverse associations between area-level 
socioeconomic disadvantage and all CMRFs except for TC after adjusting for individual-level factors. 
Total cholesterol again showed a positive association with area-level socioeconomic disadvantage. In the 
final models (M5s), the access index was found to be inversely associated with low HDL (HDL < 1 
mmol/L) and obesity (BMI ≥ 30 kg/m2), after adjusting for individual and area-level factors. Including the 
access index in the final models did not attenuate associations between area-level disadvantage and 
CMRFs observed in M4s. 
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Table 3. Multilevel logistic regression model summaries of high FBSL (FBSL ≥ 7.0 mmol/L). 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value 
High FBSL            
Intercept 0.09 (0.09–0.09) p < 0.001 0.09 (0.09–0.09) p < 0.001 0.01 (0.01–0.01) p < 0.001 0.01 (0.01–0.01) p < 0.001 0.01 (0.01–0.01) p < 0.001 
Access   0.89 (0.87–0.92) p < 0.001       
Sex: Female     Reference      
Male     1.63 (1.58–1.69) p < 0.001 1.63 (1.58–1.69) p < 0.001 1.63 (1.58–1.69) p < 0.001 
Age:18–29     Reference      
30–39     1.63 (1.40–1.90) p < 0.001 1.65 (1.41–1.92) p < 0.001 1.65 (1.41–1.92) p < 0.001 
40–49     3.53 (3.08–4.05) p < 0.001 3.57 (3.11–4.10) p < 0.001 3.57 (3.11–4.10) p < 0.001 
50–59     6.77 (5.93–7.72) p < 0.001 6.81 (5.97–7.77) p < 0.001 6.80 (5.97–7.75) p < 0.001 
60–69     11.07 (9.72–12.6) p < 0.001 11.07 (9.7–12.6) p < 0.001 11.05 (9.7–12.6) p < 0.001 
70–79     13.93 (12.2–15.9) p < 0.001 13.8 (12.1–15.7) p < 0.001 13.8 (12.1–15.7) p < 0.001 
80+     12.33 (10.8–14.1) p < 0.001 12.1(10.6–13.9) p < 0.001 12.1(10.6–13.8) p < 0.001 
IRSD        0.79 (0.77–0.80) p < 0.001 0.79 (0.77–0.81) p < 0.001 
Access          0.98 (0.96–1.00) 0.111 
AIC 111,022.8 110,962.3 103,066.2 102,652.6 102,652.0 
Variance 0.101 0.091 0.103 0.040 0.039 
PCV - −9.98% +1.88% −60.90% −61.05%   
ICC (%) 3.0 2.7 3.0 1.2 1.2 
MOR 1.36 1.334 1.36 1.209 1.209 
Proportional variance explained by Access to primary care: −0.38%    
AIC - Akaike Information Criterion; FBSL—fasting blood sugar level; ICC - Intra-cluster correlation coefficient; IRSD—Index of Relative Socioeconomic Disadvantage; LRT 
- Likelihood ratio test; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; Model 3—M1 + individual-level: age + sex; Model 4—Model 
3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care access index of SA1s; SA1 — Statistical area-level 1; MOR - 
Median odds ratio; PCV - Proportional change in variance.
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Table 4. Multilevel logistic regression model summaries of high HbA1c (HbA1c > 7.5%). 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value 
High HbA1c            
Intercept 0.12 (0.11–0.12) p < 0.001 0.12 (0.11–0.12) p < 0.001 0.07 (0.06–0.07) p < 0.001 0.07(0.06–0.08) p < 0.001 0.07 (0.06–0.08) p < 0.01 
Access   0.95(0.92–0.98) p < 0.001       
Sex: Female     Reference      
Male     1.38 (1.3–1.45) p < 0.001 1.39(1.32–1.45) p < 0.001 1.39(1.32 -1. 45) p < 0.001 
Age:18—29     Reference      
30—39     0.81 (0.68–0.96) p < 0.01 0.81 (0.68–0.96) p < 0.01 0.81 (0.68–0. 97) p < 0.01 
40—49     1.24 (1.07–1.44) p < 0.001 1.25 (1.08–1.45) p < 0.001 1.26 (1.08–1. 46) p < 0.001 
50—59     1.56 (1.36–1.80) p < 0.001 1.56 (1.36–1.80) p < 0.001 1.57 (1.36–1. 81) p < 0.001 
60—69     1.64 (1.43–1.88) p < 0.001 1.64 (1.43–1.88) p < 0.001 1.64 (1.43–1. 89) p < 0.001 
70—79     1.64 (1.42–1.88) p < 0.001 1.62 (1.41–1.86) p < 0.001 1.63 (1.42–1. 87) p < 0.001 
80+     1.63 (1.41–1.88) p < 0.001 1.62 (1.40–1.87) p < 0.001 1.62 (1.41–1. 87) p < 0.001 
IRSD        0.79 (0.77–0.81) p < 0.001 0.79 (0.77–0. 81) p < 0.001 
Access          1.00 (0.97–1.03) 0.750 
AIC 50,114.5 50,105.9 49,690.2 49,438.2 49,440.0 
Variance 0.103 0.100 0.106 0.048 0.047 
PCV - −2.430% +3.02% −53.78% −53.80% 
ICC (%) 3.0 3.0 3.1  1.4 1.4 
MOR 1.36 1.353 1.358 1.231 1.231 
Proportional variance explained by Access to primary care: –0.04%    
AIC - Akaike Information Criterion; HbA1c—glycated haemoglobin; ICC - Intra-cluster correlation coefficient; IRSD—Index of Relative Socioeconomic Disadvantage; LRT 
- Likelihood ratio test; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; Model 3—M1 + individual-level: age + sex; Model 4—Model 
3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care access index of SA1s; SA1 — Statistical area-level 1; MOR - 
Median odds ratio; PCV - Proportional change in variance.
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Table 5. Multilevel logistic regression model summaries of high TC (TC ≥ 5.5 mmol/L). 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value 
high TC            
Intercept 0.42 (0.41–0.43) p < 0.001 0.42 (0.41- 0.43) p < 0.001 0.20 (0.19–0.21) p < 0.001 0.20 (0.19–0.21) p < 0.001 0.20 (0.19–0.21) p < 0.01 
Access   1.02 (1.00–1.03) p < 0.01       
Sex: Female     Reference      
Male     0.69 (0.68–0.71) p < 0.001 0.69 (0.68–0.71) p < 0.001 0.69 (0.68–0.71) p < 0.001 
Age:18–29     Reference      
30–39     2.02 (1.91–2.14) p < 0.001 2.01 (1.90–2.13) p < 0.01 2.01 (1.90–2.13) p < 0.001 
40–49     3.01 (2.86–3.17) p < 0.001 3.00 (2.85–3.16) p < 0.001 3.00 (2.85–3.16) p < 0.001 
50–59     4.08 (3.88–4.29) p < 0.001 4.07 (3.87–4.28) p < 0.001 4.07 (3.87–4.28) p < 0.001 
60–69     2.95 (2.80–3.10) p < 0.001 2.95 (2.80–3.10) p < 0.001 2.95 (2.80–3.10) p < 0.001 
70–79     1.60 (1.52–1.69) p < 0.001 1.61 (1.52–1.69) p < 0.001 1.61 (1.52–1.69) p < 0.001 
80+     1.13 (1.07–1.20) p < 0.001 1.14 (1.07–1.21) p < 0.001 1.14 (1.07–1.21) p < 0.001 
IRSD        1.06 (1.04–1.07) p < 0.001 1.06 (1.04–1.07) p < 0.001 
Access          1.00 (0.98–1.01) 0.616 
AIC 235,931.6 235,927.9 227,254.6 227,193.8 227,195.5 
Variance 0.0255 0.0250 0.020 0.01703 0.01705 
PCV - −1.69% −21.76% −33.11% −33.07% 
ICC (%) 0.8 0.8 0.6 0.5 0.5 
MOR 1.16 1.163 1.14 1.133 1.133 
Proportional variance explained by Access to primary care: +0.12%    
AIC - Akaike Information Criterion; TC—total cholesterol; ICC - Intra-cluster correlation coefficient; IRSD—Index of Relative Socioeconomic Disadvantage; LRT - 
Likelihood ratio test; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; Model 3—M1 + individual-level: age + sex; Model 4—Model 3 
+ Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care access index of SA1s; SA1 — Statistical area-level 1; MOR - 
Median odds ratio; PCV - Proportional change in variance.
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Table 6. Multilevel logistic regression model summaries of low HDL (<1 mmol/l). 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value 
low HDL            
Intercept 0.13 (0.13–0.13) p < 0.001 0.13 (0.13–0.18) p < 0.001 0.06 (0.06–0.07) p < 0.001 0.06 (0.06–0.07) p < 0.001 0.06 (0.06–0.07) p < 0.001 
Access   0.92(0.90–0.94) p < 0.001       
Sex: Female     Reference      
Male     3.98 (3.85–4.11) p < 0.001 3.98 (3.85–4.11) p < 0.001 3.98 (3.85–4.11) p < 0.001 
Age:18–29     Reference      
30–39     1.11 (1.03–1.20) p < 0.001 1.12 (1.04–1.21) p < 0.001 1.12 (1.04–1.21) p < 0.001 
40–49     0.99 (0.92–1.05) 0.658 1.00 (0.93–1.07) 0.957 1.00 (0.93–1.07) 0.947 
50–59     0.88 (0.82–0.94) p < 0.001 0.89 (0.83–0.95) p < 0.001 0.88 (0.83–0.95) p < 0.001 
60–69     0.82 (0.77–0.88) p < 0.001 0.83 (0.77–0.88) p < 0.001 0.82 (0.77–0.88) p < 0.001 
70–79     0.86 (0.80–0.92) p < 0.001 0.85 (0.80–0.91) p < 0.001 0.85 (0.79–0.91) p < 0.001 
80+     0.93 (0.86–1.00) p < 0.010 0.92 (0.85–0.99) p < 0.010 0.91 (0.85–0.99) p < 0.010 
IRSD        0.81 (0.80–0.82) p < 0.001 0.82 (0.80–0.83) p < 0.001 
Access          0.95 (0.93–0.97) p < 0.001 
AIC 130,649.70 130,601.4 122,700.0 122,291.9 122,271.4 
Variance 0.07 0.064 0.081 0.031 0.029 
PCV - −9.48% +15.25% −55.90% −59.05% 
ICC (%) 2.1 1.9 2.4 0.9 0.9 
MOR 1.289 1.273 1.313 1.183 1.183 
Proportional variance explained by Access to primary care: –6.61%   6.61% 
AIC - Akaike Information Criterion; HDL—high density lipoprotein; ICC - Intra-cluster correlation coefficient; IRSD—Index of Relative Socioeconomic Disadvantage; LRT 
- Likelihood ratio test; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; Model 3—M1 + individual-level: age + sex; Model 4—Model 
3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care access index of SA1s; SA1 — Statistical area-level 1; MOR - 
Median odds ratio; PCV - Proportional change in variance.
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Table 7. Multilevel logistic regression model summaries of high ACR (≥30 mcg/L to mg/L). 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value 
High ACR            
Intercept 0.04 (0.04–0.04) p < 0.001 0.04 (0.04–0.04) p < 0.001 0.02 (0.02–0.03) p < 0.001 0.02 (0.02–0.03) p < 0.001 0.02 (0.02–0.03) p < 0.001 
Access    0.91 (0.86–0.96) p < 0.001       
Sex: Female     Reference      
Male     1.75 (1.60–1.92) p < 0.001 1.76 (1.60–1.93) p < 0.001 1.75 (1.60–1.92) p < 0.001 
Age:18–29     Reference      
30–39     1.00 (0.69–1.45) 0.985 1.01 (0.69–1.46) 0.978 1.00 (0.69–1.46) 0.982 
40–49     0.69 (0.47–0.97) p < 0.01 0.70 (0.50–1.00) p < 0.01 0.70 (0.50–1.00) p < 0.01 
50–59     0.77 (0.56–1.05) 0.101 0.77 (0.56–1.07) 0.115 0.77 (0.56–1.06) 0.115 
60–69     0.95 (0.70–1.30) 0.762 0.96 (0.71–1.31) 0.794 0.96 (0.70–1.30) 0.777 
70–79     1.55 (1.15–2.10) p < 0.001 1.55 (1.14–2.09) p < 0.001 1.54 (1.14–2.08) p < 0.001 
80+     2.74 (2.02–3.71) p < 0.001 2.71 (2.00–3.67) p < 0.001 2.70 (1.99–3.66) p < 0.001 
IRSD        0.82 (0.78–0.85) p < 0.001 0.82 (0.79–0.86) p < 0.001 
Access          0.97 (0.91–1.02) 0.206 
AIC 17,130.0 17,119.9 16,585.2 16,510.8 16,511.2 
Variance 0.092 0.085 0.073 0.028 0.025 
PCV - −7.92% −20.53% −69.14% −72.39% 
ICC (%) 2.7 2.5 2.2 0.9 0.8 
MOR 1.34 1.321 1.30 1.175 1.165 
Proportional variance explained by Access to primary care: −10.53%    
AIC - Akaike Information Criterion; ACR–albumin creatinine ratio; ICC - Intra-cluster correlation coefficient; IRSD—Index of Relative Socioeconomic Disadvantage; LRT 
- Likelihood ratio test; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; Model 3—M1 + individual-level: age + sex; Model 4—Model 
3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care access index of SA1s; SA1 — Statistical area-level 1; MOR - 
Median odds ratio; PCV - Proportional change in variance.
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Table 8. Multilevel logistic regression model summaries of low eGFR (<60 mL/min/1.73m2). 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value 
Low eGFR            
Intercept 0.11 (0.11–0.12) p < 0.001 0.11 (0.11–0.12) p < 0.001 0.00 (0.00–0.00) p < 0.001 0.00 (0.00–0.00) p < 0.001 0.00 (0.00–0.00) p < 0.001 
Access    0.89 (0.86–0.92) p < 0.001       
Sex: Female     Reference      
Male     0.98 (0.95–1.01) 0.208 0.98(0.95–1.01) 0.258 0.98 (0.95–1.01) 0.248 
Age:18–29     Reference      
30–39     1.66 (1.25–2.20) p < 0.001 1.66 (1.24–2.23) p < 0.001 1.65 (1.22–2.24) p < 0.001 
40–49     4.26 (3.35–5.41) p < 0.001 4.27 (3.34–5.50) p < 0.001 4.30 (3.32–5.58) p < 0.001 
50–59     12.26 (9.8–15.3) p < 0.001 12.29 (9.73–15.52) p < 0.001 12.28 (9.63–15.66) p < 0.001 
60–69     41.8 (33.6–51.8) p < 0.001 41.84 (33.29–52.57) p < 0.001 41.83 (32.97–53.06) p < 0.001 
70–79     150.7 (121.3–187.1) p < 0.001 149.69 (119.3–187.9) p < 0.001 149.6 (118.1–189.5) p < 0.001 
80+     509.3 (410.1–632.4) p < 0.001 503.19 (400.9–631.6) p < 0.001 503.0 (396.9–637.4) p < 0.001 
IRSD        0.90 (0.88–0.91) p < 0.001 0.90 (0.88–0.91) p < 0.001 
Access          1.00 (0.98–1.02) 0.925 
AIC 167,164.8 167,113.4 115,257.1 115,109.2 115,111.2 
Variance 0.189 0.176 0.024 0.013 0.013 
PCV - −6.53% −87.26% −93.31% −93.26% 
ICC (%) 5.4 5.1 0.7 0.4 0.4 
MOR 1.51 1.492 1.16 1.113 1.113 
Proportional variance explained by Access to primary care: (+) 0.63%    
AIC - Akaike Information Criterion; eGFR—estimated glomerular filtration rate; ICC - Intra-cluster correlation coefficient; IRSD—Index of Relative Socioeconomic 
Disadvantage; LRT - Likelihood ratio test; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; Model 3—M1 + individual-level: age + sex; 
Model 4—Model 3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care access index of SA1s; SA1 — Statistical 
area-level 1; MOR - Median odds ratio; PCV - Proportional change in variance. 
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Table 9. Multilevel logistic regression model summaries of obesity (BMI ≥ 30 kg/m2). 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value 
Obesity            
Intercept 0.51 (0.50–0.52) p < 0.001 0.51 (0.50–0.52) p < 0.001 0.25 (0.24–0.26) p < 0.001 0.25(0.24–0.25) p < 0.001 0.25(0.24–0.26) p < 0.001 
Access    0.88 (0.86–0.90) p < 0.001       
Sex: Female     Reference      
Male     0.99(0.97–1.01) 0.214 0.99(0.97–1.01) 0.195 0.99(0.97–1.01) 0.193 
Age:18–29     Reference      
30–39     1.63 (1.56–1.71) p < 0.001 1.64 (1.57–1.71) p < 0.001 1.64 (1.57–1.71) p < 0.001 
40–49     2.20 (2.11–2.29) p < 0.001 2.21 (2.12–2.30) p < 0.001 2.20 (2.12–2.30) p < 0.001 
50–59     2.44 (2.34–2.53) p < 0.001 2.45 (2.35–2.54) p < 0.001 2.44 (2.34–2.53) p < 0.001 
60–69     2.73 (2.63–2.84) p < 0.001 2.74 (2.63–2.85) p < 0.001 2.72 (2.62–2.83) p < 0.001 
70–79     2.44 (2.34–2.54) p < 0.001 2.44 (2.34–2.54) p < 0.001 2.42 (2.33–2.52) p < 0.001 
80+     1.46 (1.39–1.55) p < 0.001 1.45 (1.38–1.54) p < 0.001 1.45 (1.37–1.53) p < 0.001 
IRSD        0.81 (0.79–0.82) p < 0.001 0.82 (0.80–0.83) p < 0.001 
Access          0.93 (0.91–0.95) p < 0.001 
AIC 242,793.2 242,686.2 239,122.6 238,731.8 238,680.6 
Variance 0.115 0.099 0.117 0.068 0.062 
PCV - −14.20% +1.48% −41.21% −46.19% 
ICC (%) 3.4 2.9 3.4 2.0 1.8 
MOR 1.38 1.350 1.39 1.282 1.268 
Proportional variance explained by Access to primary care: –8.47%    
AIC - Akaike Information Criterion; BMI—body mass index; ICC - Intra-cluster correlation coefficient; IRSD—Index of Relative Socioeconomic Disadvantage; LRT - 
Likelihood ratio test; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; Model 3—M1 + individual-level: age + sex; Model 4—Model 3 
+ Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care access index of SA1s; SA1 — Statistical area-level 1; MOR - 
Median odds ratio; PCV - Proportional change in variance. 
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Model fit of the nested models of each CMRF were compared using the Akaike Information Criterion 
(AIC). The AIC estimated the out-of-sample prediction error rates of individual models and thus the 
relative quality of individual models for a given set of nested models [56]. Reductions in the AIC values 
were observed for all CMRFs models, except in TC and eGFR, from the null model (M1) to the final model 
(M5), indicating a better fit of the final models. The AIC for TC and eGFR models indicated M4 was the 
best fitting model for these CMRFs. 
In the null models (M1s), low eGFR demonstrated the most area-level variance and high TC showed 
the least. The access only models (M2s) showed a reduction in the residual variance of all CMRFs from 
those of null models. In Model 3s, adjusting for age and sex initially increased the residual variance of 
FBSL (PCV = +1.9%), HbA1c (PCV = +3.0%), HDL (PCV = +15.3%) and BMI (PCV = +1.5%). In Model 4s, 
adjusting the CMRFs for individual-level age and sex and area-level disadvantage resulted in major 
reductions of variance from −33.1% (in TC) to −93.3% (in eGFR). In the final models (M5s), including access 
index in the models after adjusting for the covariates extended the reduction in variance in all CMRFs, 
except for TC and eGFR. Including the access index had been observed to increase the variance in the TC 
and eGFR final models, compared with the lower level model. 
Similarly, in the unadjusted models, the MORs, which indicate the odds of having a higher risk 
CMRF test result for a person from the most, compared to the least, area-level disadvantage, were the 
highest among eGFR (τ2 = 0.189; ICC = 5.4%; MOR = 1.51) and the least among TC (τ2 = 0.025; ICC = 0.8%; 
MOR = 1.16). The ICCs of CMRFs in all the models were comparatively small (Table 4) in all the models, 
indicating minimal contextual effect of areas on any of the CMRFs. In the fully adjusted models, the ICCs 
further reduced and ranged between 0.4% and 1.8% in low eGFR and BMI respectively. Table 10 presents 
a summary and comparison of the model fit. 
Table 10. Summary of model fit values and comparison of the models. 
  FBSL HbA1c TC HDL ACR eGFR Obesity 
Model 1 Null Model 
 AIC 111,022.8 50,114.5 235,931.6 130,649.7 17,130.0 167,164.8 242,793.2 
    0.101 0.103 0.025 0.071 0.092 0.189 0.115 
 ICC (%) 3.0 3.0 0.8 2.1 2.7 5.4 3.4 
 MOR 1.36 1.36 1.16 1.29 1.34 1.51 1.38 
Model 2 Access Model  
 
  
AIC 110,962.3 50,105.9 235,927.9 130,601.4 17,119.9 167,113.4 242,686.2 
   0.091 0.100 0.025 0.064 0.085 0.176 0.099 
ICC (%) 2.7 3.0 0.8 1.9  2.5 5.1 2.9 
 MOR 1.334 1.353 1.163 1.273 1.321 1.492 1.350 
 PCV −9.98% −2.430% −1.69% −9.48% −7.92% −6.53% −14.20% 
Model 3 Sex + Age Adjusted Model 
 
 
  
AIC 103,066.2 49,690.2 227,254.6 122,700.0 16,585.2 115,257.1 239,122.6 
   0.103 0.106 0.020 0.081 0.073 0.024 0.117 
ICC (%) 3.0 3.1 0.6 2.4 2.2 0.7 3.4 
MOR 1.36 1.358 1.14 1.31 1.30 1.16 1.39 
PCV + 1.88% + 3.02% −21.76% +15.25% −20.53% −87.26% +1.48% 
Model 4 Sex + Age + IRSD Adjusted Model  
 AIC 102,652.6 49,438.2 227,193.8 122,291.9 16,510.8 115,109.2 238,731.8 
    0.040 0.048 0.017 0.031 0.028 0.013 0.068 
 ICC (%) 1.2 1.4 0.5 0.9 0.9 0.4 2.0 
 MOR 1.209 1.231 1.133 1.183 1.175 1.113 1.282 
 PCV −60.90% −53.78% −33.11% −55.90% −69.14% −93.31% −41.21% 
Model 5 Sex + Age + IRSD Adjusted and Access included Model 
 AIC 102,652.0 49,440.0 227,195.5 122,271.4 16,511.2 115,111.2 238,680.6 
    0.039 0.047 0.017 0.029 0.025 0.013 0.062 
 ICC (%) 1.2 1.4 0.5 0.9 0.8 0.4 1.8 
 MOR 1.209 1.231 1.133 1.183 1.165 1.113 1.268 
 PCV −61.05% −53.80% −33.07% −59.05% −72.39% −93.26% −46.19% 
AIC—Akaike Information Criterion; τ^2—residual variance; IC—intra-cluster correlation coefficients; 
MOR—median odds ratio; PCV—proportional change in variance; FBSL—fasting blood sugar level; 
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HbA1c—glycated haemoglobin; TC—total cholesterol; HDL—high density lipoprotein; ACR—albumin 
creatinine ratio; eGFR—estimated glomerular filtration rate. 
4. Discussion 
This study aimed to inform area-specific interventions for the prevention and control of CMRFs, 
based on the primary care access status of the small areas within Illawarra-Sholhaven region of NSW, 
Australia. After adjusting for the covariates, we found that: a) greater access to primary care was 
associated with a reduction in the odds of low HDL and obesity but was not associated with high FBSL, 
high HbA1C, high TC, high ACR and low eGFR; b) the general contextual effect of areas on each of the 
CMRFs were minimal; and c) the geographic variation of CMRFs specifically explained by primary care 
access was small and did not demonstrate any attenuating effect on the contribution of area-level 
disadvantage on the variation of CMRFs in the study region. The results demonstrate that though the 
probability of low HDL and obesity decreases with increasing primary care access, the low general 
contextual effects of the areas on each of the CMRFs (i.e., low ICCs of Model 3s, ranges 0.6–3.4%) indicate 
minimal difference between the small areas after controlling for the study variables. Thus, the findings 
suggest that preventive interventions should not only be focused on areas with lower primary care access. 
Rather, interventions should be universal but proportional to the need and risk level of the people for the 
prevention and control of CMRFs. Primary care access was associated with all CRMFs in unadjusted 
models but only with low HDL and obesity in models fully adjusted for individual- and area-level 
covariates. These findings support the arguments of the possible role of confounders and reverse causality 
in ecological models [57], which question the previously established associations between primary care 
access and improved health [58,59]. The study suggests higher odds of being identified with low HDL 
and obesity with reduced access to primary care. In previous studies, when the relationship between 
health care service outcomes and travel time was modelled using multilevel logistic regression, it was 
found that GP consultations were less likely to happen when the travel time was longer, which is more 
common in rural areas [21]. The current study outcomes are consistent with those findings. However, it 
should also be noted that the current findings pertain only to the geographical/spatial accessibility of the 
primary health care services within 30 km distance of an SA1 centroid, rather than their road network 
access, actual usage and affordability. 
The primary care access index, derived from the study region, ranged from 0 to 5.41 general 
practitioners per 1000 people (mean = 2.1, SD = 0.77). Multiple previous studies have reported inequalities 
in the geographic access to primary care services, using different enhanced versions of the 2SFCA method 
[45,60–68]. For example, the spatial accessibility index derived from rural Otago in New Zealand, using 
the travel time distance, ranged between 1 to 10, where a higher score indicated better access [62]. The 
accessibility index reported from Thimphu district in Bhutan ranged between 0 and 1, where 1 was the 
maximum access [69]. The spatial accessibility index of GP accessibility in England has been reported to 
range between 7.2 (South of England) and 13.3 (in London) [69]. The access map of the study region 
(Figure 2) clearly shows a polarisation of the higher access indices along the northern and southern ends 
of the study region, thus a visible inequality in their distribution. The WHO recommends universal access 
to primary care for all populations, where geographic access is one part of physical access to primary care 
[70]. 
Area-level disadvantage explained more geographic variation in CMRFs than area-level access to 
primary care. Inclusion of the access index in the final model did not demonstrate any reduction in the 
variance explained by area-level disadvantage on the geographic variation of CMRFs. This finding 
supports the importance of overall socioeconomic development of areas to reduce CMRF risk. Moreover, 
the ICC values of the final models were too small to suggest any meaningful area-level difference in the 
modelled CMRF variables. This would support the call for universal approaches for the prevention and 
control of CMRFs rather than any targeted area-level approaches, but with a proportional priority to 
disadvantaged populations in the study region [24,28,71]. 
This study has to be considered within its limitations. First, the cross-sectional nature of the study 
does not support causal inference. Second, the CMRF data used in this study are from people already 
utilising health care service in the study area, so care should be taken in generalising the results to the 
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overall population. The SIMLR database does not include hospital or emergency service based tests. 
Therefore we believe that the database has a reasonable representation of community dwelling adults in 
the study region. However, it should be noted that the study sample includes only people who have 
accessed health care and pathology services, and the omission of those who have not accessed care may 
have biased our results. Given our population coverage this seem unlikely. Third, the study used a radial 
buffer distance of 30km for access calculations rather than travel time/distance because proprietary road 
network data were unavailable for this study. Thus, the patients’ actual experiences of seeking physical 
access in daily life need not exactly reflect the compound measure of access index adopted in this study. 
Even though the 30km buffer distance helped to include a maximum coverage of the population in 
relation to the geographic location of the primary care providers, this distance might have also influenced 
the discriminatory accuracy of the SA1s in the multilevel analyses. In addition, it should also be noted 
that the access index described in the study pertains only to the geographical reachability, but not to the 
affordability and acceptability of the available services. Forth, the study did not include blood pressure 
as a variable, although it is a major CMRF, due to non-availability of data. We were also unable to adjust 
for ethnicity for the same reason. 
The main strength of this study is the use of a large population-derived database comprising a wide 
range of CMRFs. The research adds to the very few studies which consider multiple CMRF variables from 
the same region [18–20,72–74] and is unusual for its hierarchical analysis of the associations between a 
range of CMRFs and primary care access in a widely dispersed population. 
Future research is required to investigate other area-level attributes contributing to the geographic 
variation of CMRFs in the study region. Our previous research has reported that area-level disadvantage 
contributes 14.7–57.8% of the geographic variation in CMRFs. The current study extended the previous 
findings by identifying the specific contribution of area-level primary care access, ranging between 0.0–
10.5%. Further area-level analyses are required to identify other factors contributing to the geographic 
inequality of the CMRFs in the study region. 
5. Conclusions 
The findings of the study suggest that adults residing in areas that have a poor primary care access 
are more likely to be identified with low HDL and obesity. However, the specific contribution of area-
level primary care access was small when compared to the contribution of area-level disadvantage. The 
finding supports the importance of overall socioeconomic development of areas to reduce CMRF risk, 
while supporting universal approaches for the prevention and control of CMRFs which are proportional 
to the need and disadvantage level of the individuals. Future research including other aspects of primary 
care access such as road-network access, financial affordability and acceptance of the services might help 
to provide an overall picture of the contributing role of primary care in the study region. 
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